# Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus

> **NCT02507362** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Keratoconus

## Interventions

- **RADIATION:** adjusted corneal collagen cross-linking
- **RADIATION:** accelerated corneal collagen cross-linking
- **DRUG:** riboflavin 0.1% combined with dextran 20 %
- **PROCEDURE:** epithelial debridement

## Key facts

- **NCT ID:** NCT02507362
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507362, "Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02507362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*